229 related articles for article (PubMed ID: 35662287)
1. Hyaluronan synthase 2, a target of miR-200c, promotes carbon tetrachloride-induced acute and chronic liver inflammation via regulation of CCL3 and CCL4.
Kim SM; Song GY; Shim A; Lee JH; Eom CB; Liu C; Yang YM; Seki E
Exp Mol Med; 2022 Jun; 54(6):739-752. PubMed ID: 35662287
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronan synthase 2-mediated hyaluronan production mediates Notch1 activation and liver fibrosis.
Yang YM; Noureddin M; Liu C; Ohashi K; Kim SY; Ramnath D; Powell EE; Sweet MJ; Roh YS; Hsin IF; Deng N; Liu Z; Liang J; Mena E; Shouhed D; Schwabe RF; Jiang D; Lu SC; Noble PW; Seki E
Sci Transl Med; 2019 Jun; 11(496):. PubMed ID: 31189722
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of Hyaluronan synthase 2 suppresses liver fibrosis in mice via induction of transcriptomic changes similar to 4MU treatment.
Halimani N; Nesterchuk M; Tsitrina AA; Sabirov M; Andreichenko IN; Dashenkova NO; Petrova E; Kulikov AM; Zatsepin TS; Romanov RA; Mikaelyan AS; Kotelevtsev YV
Sci Rep; 2024 Feb; 14(1):2797. PubMed ID: 38307876
[TBL] [Abstract][Full Text] [Related]
4. miR-345-5p curbs hepatic stellate cell activation and liver fibrosis progression by suppressing hypoxia-inducible factor-1alpha expression.
Wang P; Fang Y; Qiu J; Zhou Y; Wang Z; Jiang C
Toxicol Lett; 2022 Nov; 370():42-52. PubMed ID: 36126797
[TBL] [Abstract][Full Text] [Related]
5. 4-methylumbelliferone Prevents Liver Fibrosis by Affecting Hyaluronan Deposition, FSTL1 Expression and Cell Localization.
Andreichenko IN; Tsitrina AA; Fokin AV; Gabdulkhakova AI; Maltsev DI; Perelman GS; Bulgakova EV; Kulikov AM; Mikaelyan AS; Kotelevtsev YV
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31847129
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-503 Targets Mothers Against Decapentaplegic Homolog 7 Enhancing Hepatic Stellate Cell Activation and Hepatic Fibrosis.
Xie X; Dou CY; Zhou Y; Zhou Q; Tang HB
Dig Dis Sci; 2021 Jun; 66(6):1928-1939. PubMed ID: 32648079
[TBL] [Abstract][Full Text] [Related]
7. PSMP/MSMP promotes hepatic fibrosis through CCR2 and represents a novel therapeutic target.
She S; Wu X; Zheng D; Pei X; Ma J; Sun Y; Zhou J; Nong L; Guo C; Lv P; Song Q; Zheng C; Liang W; Huang S; Li Q; Liu Z; Song Z; Li Y; Zhang Y; Kong W; You H; Xi J; Wang Y
J Hepatol; 2020 Mar; 72(3):506-518. PubMed ID: 31813573
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-30a Suppresses the Activation of Hepatic Stellate Cells by Inhibiting Epithelial-to-Mesenchymal Transition.
Zheng J; Wang W; Yu F; Dong P; Chen B; Zhou MT
Cell Physiol Biochem; 2018; 46(1):82-92. PubMed ID: 29587268
[TBL] [Abstract][Full Text] [Related]
9. Thymosin β4 suppresses CCl
Li H; Li Q; Zhang X; Zheng X; Zhang Q; Hao Z
J Gene Med; 2018 Sep; 20(9):e3043. PubMed ID: 29972714
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of Idelalisib on carbon tetrachloride-induced liver fibrosis via microRNA-124-3P/phosphatidylinositol-3-hydroxykinase signalling pathway.
Li X; Li H; Zhang S; Zhang R; Li J; Wei Y; Yang C; Zhang F; Zhou H
J Cell Mol Med; 2021 Dec; 25(24):11185-11197. PubMed ID: 34747105
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory Effect of Sestrin 2 on Hepatic Stellate Cell Activation and Liver Fibrosis.
Yang JH; Kim KM; Cho SS; Shin SM; Ka SO; Na CS; Park BH; Jegal KH; Kim JK; Ku SK; Lee HJ; Park SG; Cho IJ; Ki SH
Antioxid Redox Signal; 2019 Jul; 31(3):243-259. PubMed ID: 30909713
[No Abstract] [Full Text] [Related]
12. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis.
Roderburg C; Urban GW; Bettermann K; Vucur M; Zimmermann H; Schmidt S; Janssen J; Koppe C; Knolle P; Castoldi M; Tacke F; Trautwein C; Luedde T
Hepatology; 2011 Jan; 53(1):209-18. PubMed ID: 20890893
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-195-3p promotes hepatic stellate cell activation and liver fibrosis by suppressing PTEN expression.
Wang A; Bu FT; Li JJ; Zhang YF; Jia PC; You HM; Wu S; Wu YY; Zhu S; Huang C; Li J
Toxicol Lett; 2022 Feb; 355():88-99. PubMed ID: 34838997
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
Tu X; Zhang H; Zhang J; Zhao S; Zheng X; Zhang Z; Zhu J; Chen J; Dong L; Zang Y; Zhang J
J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
[TBL] [Abstract][Full Text] [Related]
15. PGE
Brea R; Motiño O; Francés D; García-Monzón C; Vargas J; Fernández-Velasco M; Boscá L; Casado M; Martín-Sanz P; Agra N
Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):325-337. PubMed ID: 29109031
[TBL] [Abstract][Full Text] [Related]
16. miR-144 regulates transforming growth factor-β1 iduced hepatic stellate cell activation in human fibrotic liver.
Liu Z; Yi J; Ye R; Liu J; Duan Q; Xiao J; Liu F
Int J Clin Exp Pathol; 2015; 8(4):3994-4000. PubMed ID: 26097586
[TBL] [Abstract][Full Text] [Related]
17. Adiponectin inhibits hepatic stellate cell activation by targeting the PTEN/AKT pathway.
Kumar P; Raeman R; Chopyk DM; Smith T; Verma K; Liu Y; Anania FA
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3537-3545. PubMed ID: 30293572
[TBL] [Abstract][Full Text] [Related]
18. The mouse Anxa6/miR-9-5p/Anxa2 axis modulates TGF-β1-induced mouse hepatic stellate cell (mHSC) activation and CCl
Liao J; Zhang Z; Yuan Q; Luo L; Hu X
Toxicol Lett; 2022 Jun; 362():38-49. PubMed ID: 35483553
[TBL] [Abstract][Full Text] [Related]
19. CD248/endosialin critically regulates hepatic stellate cell proliferation during chronic liver injury via a PDGF-regulated mechanism.
Wilhelm A; Aldridge V; Haldar D; Naylor AJ; Weston CJ; Hedegaard D; Garg A; Fear J; Reynolds GM; Croft AP; Henderson NC; Buckley CD; Newsome PN
Gut; 2016 Jul; 65(7):1175-85. PubMed ID: 26078290
[TBL] [Abstract][Full Text] [Related]
20. MiR-552-3p Regulates Multiple Fibrotic and Inflammatory genes Concurrently in Hepatic Stellate Cells Improving NASH-associated Phenotypes.
Ma N; Hou A; Pan X; Sun F; Xu X; Yu C; Lai R; Huang R; Gong L; Xie Q; Chen J; Ren J
Int J Biol Sci; 2023; 19(11):3456-3471. PubMed ID: 37496991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
